https://www.selleckchem.com/products/unc-3230.html
In addition, in the model of delayed GE induced by loperamide and cisplatin, C. aurantium L. administration reversed the GE deficit. Furthermore, C. aurantium L. significantly reduced gastric cancer proliferation. Conclusion The results indicate that C. aurantium L. could become a new drug for gastrointestinal prokinetic and gastric cancer therapy.The pandemic of COVID-19 presented an enormous challenge to the medical world in terms of diagnosis, treatment and health-care management as well as service organisation and provision. This n
Mi piace
Commento
Condividi
